Valuation: RaySearch Laboratories AB

Market Cap 6.45B 645M 576M 536M 487M 920M 62.41B 924M 2.53B 31.82B 2.42B 2.37B 102B P/E 2026 *
24.6x
P/E 2027 * 19.8x
Enterprise Value 6.61B 661M 591M 550M 500M 944M 64.01B 948M 2.59B 32.64B 2.48B 2.43B 105B EV / Sales 2026 *
4.78x
EV / Sales 2027 * 4.01x
Free-Float
80.09%
Yield 2026 *
2.09%
Yield 2027 * 2.35%
1 day+7.52%
1 week+7.52%
Current month+7.52%
1 month-10.45%
3 months-26.08%
6 months-9.35%
Current year-25.46%
1 week 17.74
Extreme 17.74
17.74
1 month 16.49
Extreme 16.4925
17.74
Current year 16.49
Extreme 16.4925
24.62
1 year 16.49
Extreme 16.4925
25.5
3 years 8
Extreme 8
37.36
5 years 4.04
Extreme 4.039
37.36
10 years 4.04
Extreme 4.039
37.36
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+7.52%+7.52% - - 645M
+0.93%+0.49%+25.38%+32.63% 243B
+1.08%+2.69%+8.57%+0.50% 155B
+2.06%+8.17%-1.31%+42.35% 150B
+1.64%+0.31%-55.21%-20.58% 61.93B
+1.15%+0.07%+15.24%+16.87% 49.12B
+2.30%+3.38%-17.09%-19.05% 48.78B
+1.41%+1.65%+24.83%+50.53% 48.08B
+3.96%+8.34%+3.33%+38.46% 47.95B
+1.08%+2.01%+31.05%+61.37% 42.62B
Average +2.31%+2.82%+3.86%+22.57% 94.01B
Weighted average by Cap. +1.51%+2.75%+7.65%+23.49%

Financials

2026 *2027 *
Net sales 1.38B 138M 123M 115M 104M 197M 13.38B 198M 542M 6.82B 519M 508M 21.89B 1.61B 161M 144M 134M 122M 230M 15.63B 231M 633M 7.97B 606M 593M 25.57B
Net income 266M 26.55M 23.71M 22.06M 20.07M 37.89M 2.57B 38.05M 104M 1.31B 99.71M 97.53M 4.2B 328M 32.8M 29.3M 27.25M 24.79M 46.8M 3.17B 47.01M 129M 1.62B 123M 120M 5.19B
Net Debt 166M 16.6M 14.83M 13.79M 12.55M 23.69M 1.61B 23.79M 65.04M 819M 62.34M 60.98M 2.63B 33M 3.3M 2.95M 2.74M 2.49M 4.71M 319M 4.73M 12.93M 163M 12.39M 12.12M 523M
Projected Income Statement - Annual - RaySearch Laboratories AB
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
CCC
Ratings Surperformance© - RaySearch Laboratories AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
191.80SEK
Average target price
297.50SEK
Spread / Average Target
+55.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - RaySearch Laboratories AB